Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W. Tseng, Alessandro Gronchi, Giovanni Grignani et al.|Cancer|2020Cited by 48
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional TARPSWG study.William W. Tseng, Francesco Barretta, Lorenzo Conti et al.|Journal of Clinical Oncology|2020Cited by 3